March 3, 2025 · Form 4 insider transaction
Anzalone Christopher Richard sold 133,333 shares of Arrowhead Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
All options were fully vested and exercisable as of March 6, 2015.